Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study [Structural Heart Disease]

Conclusions—
Caval valve implantation for the treatment of severe TR and advanced right ventricular failure is associated with a high procedural success rate and seems safe and feasible in an excessive-risk cohort. The study demonstrates hemodynamic efficacy with consistent elimination of TR-associated venous backflow and initial clinical improvement. These results encourage further trials to determine which patients benefit most from this interventional approach.

Source: Circulation: Cardiovascular Interventions - February 14, 2018 Category: Cardiology Authors: Lauten, A., Figulla, H. R., Unbehaun, A., Fam, N., Schofer, J., Doenst, T., Hausleiter, J., Franz, M., Jung, C., Dreger, H., Leistner, D., Alushi, B., Stundl, A., Landmesser, U., Falk, V., Stangl, K., Laule, M. Tags: Valvular Heart Disease Structural Heart Disease Source Type: research